Halozyme Therapeutics, Inc.
2013 Q4 - 2025 Q4 (26 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 10,774 | 0.0% | 159,650 | 12/31/2025 |
| 2025 Q2 | 8/14/2025 | 13,380 | 0.0% | 257,214 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 20,420 | 0.0% | 320,017 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 13,572 | 0.0% | 283,870 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 14,903 | 0.0% | 260,355 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 13,888 | 0.0% | 265,236 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 10,889 | 0.0% | 267,673 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 9,235 | 0.0% | 249,878 | 12/31/2023 |
| 2023 Q3 | 11/15/2023 | 9,703 | 0.0% | 254,001 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 7,939 | 0.0% | 220,111 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 8,357 | 0.0% | 218,828 | 3/31/2023 |
| 2022 Q4 | 8/11/2023 | 12,587 | 0.0% | 221,117 | 12/31/2022 |
| 2022 Q3 | 8/11/2023 | 9,370 | 0.0% | 237,010 | 9/30/2022 |
| 2022 Q2 | 8/11/2023 | 10,969 | 0.0% | 246,953 | 6/30/2022 |
| 2022 Q1 | 8/11/2023 | 9,909 | 0.0% | 247,811 | 3/31/2022 |
| 2021 Q4 | 2/16/2022 | 9,111 | 0.0% | 226,438 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 17,555 | 0.0% | 431,549 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 10,137 | 0.0% | 223,235 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 8,964 | 0.0% | 215,017 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 9,818 | 0.0% | 229,874 | 12/31/2020 |
| 2020 Q3 | 11/9/2020 | 2,066 | 0.0% | 78,629 | 9/30/2020 |
| 2020 Q2 | 8/10/2020 | 2,088 | 0.0% | 80,868 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 1,575 | 0.0% | 87,562 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 1,525 | 0.0% | 86,034 | 12/31/2019 |
| 2014 Q1 | 5/15/2014 | 865 | 0.0% | 68,056 | 3/31/2014 |
| 2013 Q4 | 5/1/2014 | 1,024 | 0.0% | 68,328 | 12/31/2013 |